Pharvaris
Pharvaris is a late-stage biopharma company developing novel, oral bradykinin B2 receptor antagonists to treat and prevent hereditary angioedema attacks.
Backed by Foresite Capital, Kurma Partners, Venbio Partners LLC
Traction is an independent job board.
This listing is read from the company’s own careers page and links straight back to it. We never receive your application.